Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed. It also adds new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment area along with a revision label v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T22:22:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.5.5) has been added along with new dates (2026-06-03, 2026-12-18, 2026-05-08, 2026-05). The previous revision (v3.5.4) was removed, signaling an update to IPD sharing materials and related study documents.
    Difference
    0.2%
    Check dated 2026-06-08T17:52:14.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a new Revision: v3.5.4 tag replacing the previous v3.5.3, indicating a minor update to the document version. This reflects metadata refresh rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-18T04:01:05.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The Taiwan site listing changes from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the Locations list, aiding accurate site identification and search filters.
    Difference
    0.0%
    Check dated 2026-05-03T14:01:43.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site/version update rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-26T08:10:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a version bump with no changes to study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-19T01:30:28.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.